Skip to the page

Data / Drug companies / Curia Spain S.a.u.

Curia Spain S.a.u.: 57 products in the FDA NDC directory, labeler code 65089

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Curia Spain S.a.u. (labeler code 65089) lists 57 products in the FDA National Drug Code Directory. By type: 57 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on April 30, 2024.

The request: Watch Curia Spain S.a.u. (FDA labeler code 65089): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
65089
Products in commercial distribution
57
Packages
61
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule III 3, Schedule IV 1
Started marketing in the last 12 months
0
Earliest marketing start
October 23, 1958
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients for compounding3459.6%
Bulk ingredients2340.4%

Products by type

TypeProductsShare
Bulk ingredients57100%

Dosage forms

Dosage formProductsShare
Powder57100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Betamethasone acetate65089-0006PowderBulk ingredientsApril 30, 2024
Upadacitinib65089-0067PowderBulk ingredientsMarch 22, 2024
Dexamethasone isonicotinate65089-0066PowderBulk ingredientsAugust 23, 2023
Dexamethasone dipropionate65089-0065PowderBulk ingredientsAugust 23, 2023
Viloxacine hydrochloride65089-0064PowderBulk ingredientsMarch 10, 2023
Alcaftadine65089-0063PowderBulk ingredientsMarch 10, 2023
Hydrocortisone aceponate65089-0061PowderBulk ingredientsJuly 20, 2021
Brexanolone65089-0060PowderBulk ingredients for compoundingFebruary 17, 2021
Hydrocortisone base65089-0059PowderBulk ingredientsDecember 1, 2020
Segesterone acetate65089-0019PowderBulk ingredients for compoundingMay 31, 2017
Obeticholic acid65089-0055PowderBulk ingredients for compoundingMay 27, 2016
Testosterone cypionate65089-0049PowderBulk ingredients for compoundingFebruary 19, 2016
Dexamethasone sodium phosphate65089-0001PowderBulk ingredients for compoundingDecember 1, 2015
Desoxycholic acid65089-0054PowderBulk ingredients for compoundingApril 29, 2015
Nikkomycin z65089-0058PowderBulk ingredients for compoundingDecember 21, 2014
Altrenogest65089-0048PowderBulk ingredientsNovember 14, 2014
Mometasone furoate65089-0025PowderBulk ingredients for compoundingApril 25, 2014
Paliperidone palmitate65089-0047PowderBulk ingredientsMarch 27, 2013
Exemestane65089-0046PowderBulk ingredientsFebruary 21, 2013
Dexamethasone65089-0045PowderBulk ingredientsFebruary 21, 2013
Ethinyl estradiol65089-0044PowderBulk ingredientsFebruary 12, 2013
Beclomethasone dipropionate65089-0010PowderBulk ingredients for compoundingMarch 23, 2012
Fludrocortisone acetate65089-0015PowderBulk ingredients for compoundingJuly 22, 2011
Abiraterone acetate65089-0051PowderBulk ingredients for compoundingApril 28, 2011
Pramipexole dihydrochloride65089-0040PowderBulk ingredientsFebruary 19, 2010

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.